{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["3(3)"],"submitter":["Boileau M"],"pubmed_abstract":["Anncaliia algerae myositis is a life-threatening, emerging microsporidiosis among immunocompromised hosts. We report a case of disseminated A algerae infection in a man previously treated with alemtuzumab. Due to failure of albendazole-based therapy, fumagillin was added as a novel approach to management, with a good clinical response and patient survival."],"journal":["Open forum infectious diseases"],"pagination":["ofw158"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5047403"],"repository":["biostudies-literature"],"pubmed_title":["Successful Treatment of Disseminated Anncaliia algerae Microsporidial Infection With Combination Fumagillin and Albendazole."],"pmcid":["PMC5047403"],"pubmed_authors":["Qvarnstrom Y","Ahmad I","Dufresne SF","Boileau M","Ferreira J","Lavallee C"],"additional_accession":[]},"is_claimable":false,"name":"Successful Treatment of Disseminated Anncaliia algerae Microsporidial Infection With Combination Fumagillin and Albendazole.","description":"Anncaliia algerae myositis is a life-threatening, emerging microsporidiosis among immunocompromised hosts. We report a case of disseminated A algerae infection in a man previously treated with alemtuzumab. Due to failure of albendazole-based therapy, fumagillin was added as a novel approach to management, with a good clinical response and patient survival.","dates":{"release":"2016-01-01T00:00:00Z","publication":"2016 Sep","modification":"2020-11-19T09:22:01Z","creation":"2019-03-27T02:25:42Z"},"accession":"S-EPMC5047403","cross_references":{"pubmed":["27704013"],"doi":["10.1093/ofid/ofw158"]}}